Eli Lilly stock sinks after Q3 earnings miss Wall Street expectations

Oct 30, 2024 · Eli Lilly (LLY) missed Wall Street's revenue expectations in its third quarter earnings released Wednesday morning, which sent shares down more than 6%.

6%
OFF

Eli Lilly Stock Sinks After Q3 Earnings Miss Wall Street Expectations

2 weeks from now

Oct 30, 2024 · Eli Lilly (LLY) missed Wall Street's revenue expectations in its third quarter earnings released Wednesday morning, which sent shares down more than 6%.

yahoo.com

11%
OFF

Lilly's Q3 Earnings Miss, Mounjaro, Zepbound Disappoint, Stock …

2 weeks from now

Oct 30, 2024 · Eli Lilly misses third-quarter estimates for earnings and sales. Mounjaro and Zepbound sales also miss estimates. Stock declines 11%.

yahoo.com

6%
OFF

Eli Lilly Shares Hit Yearly Low After Disappointing Q3 Earnings

2 weeks from now

Oct 31, 2024 · Shares of Eli Lilly (LLY, Financial) dipped on Wednesday by 6%, reaching its lowest since the beginning of March this year after reporting third-quarter results that blew a …

yahoo.com

10%
OFF

Eli Lilly Posts A Huge Earnings Miss. Should Investors Be Worried?

2 weeks from now

Nov 6, 2024 · Prior to earnings, Eli Lilly stock was trading at around $900. As of Monday, the stock was down to around $800, dropping more than 10% of its value in just a few days after …

nasdaq.com

10%
OFF

Eli Lilly Stock Sinks After Q3 Earnings Miss Wall Street Expectations

2 weeks from now

Oct 30, 2024 · Eli Lilly (LLY) missed Wall Street's revenue expectations in third quarter earnings released Wednesday morning, sending shares down as much as 10% in premarket trading. …

flipit.money

31%
OFF

Eli Lilly And Company Just Missed EPS By 31%: Here's What …

2 weeks from now

Eli Lilly and Company ( NYSE:LLY ) missed earnings with its latest third-quarter results, disappointing...

simplywall.st

6%
OFF

Eli Lilly Stock Down On Q4 Guidance Miss - Yahoo Finance

2 weeks from now

11 hours ago · Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations.

yahoo.com

FAQs about Eli Lilly stock sinks after Q3 earnings miss Wall Street expectations Coupon?

Does Eli Lilly miss earnings estimates?

Eli Lilly misses third-quarter estimates for earnings and sales. Mounjaro and Zepbound sales also miss estimates. Stock declines 11%. ...

Why did Eli Lilly (LLY) stock fall?

On Wednesday, Eli Lilly and Co (NYSE: LLY) stock plummeted after the company released worse-than-expected third-quarter earnings and lowered 2024 guidance. The U.S. pharma giant reported third-quarter revenue of $11.44 billion, up 20% year over year, but it missed the consensus of $12.10 billion. ...

Will Eli Lilly (LLY) stock be off on Q3 results?

After Eli Lilly (LLY) reported Q3 results that are below the Street view on sales and EPS due to Zepbound and Mounjaro wholesaler destocking and narrowed its top-line guidance to $45.4B-$46.0B while maintaining its EPS guidance ex-IPRD of $16.10-$16.60, JPMorgan assumes shares will be off on today’s results. ...

How much revenue does Eli Lilly have?

Analysts' current estimate is for $46.22 billion in revenue. Eli Lilly's (LLY) third-quarter results rose year over year but missed Wall Street expectations while the drugmaker cut its full-year earnings outlook amid acquisition-related charges. ...

How did Eli Lilly perform in Q3 2024?

Eli Lilly and Company LLY reported third-quarter 2024 adjusted earnings per share (“EPS”) of $1.18, which missed the Zacks Consensus Estimate of $1.52 per share. In the year-ago quarter, the company had reported earnings of 10 cents per share. ...

Why did Eli Lilly lose $100 in value before markets opened?

Shares of Indianapolis-based Eli Lilly and Co. shed $100 in value before markets opened, falling around 11% to $805. Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two key drugs that missed expectations. ...